Freedom Investment Management’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
LFCM
CS
B
Freedom Investment Management's CLLS Position: Q1 2022 in Review
Freedom Investment Management sold out of Cellectis (CLLS) in Q1 2022, closing a stake of 104,063 shares — an estimated $845K sold.
Freedom Investment Management first reported a position in CLLS in Q1 2017 and held it in 19 quarters. The position peaked at $2.56M in Q4 2020. 51 funds tracked by Wall St. Rank hold CLLS as of Q1 2022.
- Freedom Investment Management reported no remaining Cellectis position as of Q1 2022 after selling out during the quarter.
- Freedom Investment Management sold 104,063 Cellectis shares in Q1 2022, an estimated $845K.
- Freedom Investment Management first reported a position in Cellectis in Q1 2017 and held it in 19 quarters.
- Freedom Investment Management's Cellectis position peaked at $2.56M in Q4 2020.
- 51 funds tracked by Wall St. Rank held Cellectis as of Q1 2022.
Based on Freedom Investment Management's 13F filing for Q1 2022, filed 16 May 2022.